NS: 25332330
Mobile: 90094424
2:00 – 6:00 pm (weekdays)
Sat. 10:30 AM - 1:30 PM.

News & Articles

22/12/2020

Results of NIH-sponsored ACTIV-3 trial published

Experimental monoclonal antibody not efficacious in Phase 3 trial. Read More

22/12/2020

NIH ACTIV Trial of blood thinners pauses enrollment of critically ill COVID-19 patients

Anticoagulation drugs did not reduce the need for organ support. Read More

22/12/2020

Pregnant women in third trimester unlikely to pass SARS-CoV-2 infection to newborns

NIH-funded findings also suggest less-than-expected transfer of maternal SARS-CoV-2 antibodies through placenta. Read More

22/12/2020

NIH neuroscientists isolate promising mini antibodies against COVID-19 from a llama

Preliminary results suggest anti-COVID19 nanobodies may be effective at preventing and diagnosing infections. Read More

22/12/2020

NIH funds eight studies to uncover risk factors for COVID-19-related inflammatory syndrome in children

Awards part of a larger effort to study pediatric COVID-19 and related conditions. Read More

22/12/2020

Reston Ebolavirus spreads efficiently in pigs

Finding reveals potential for spread to humans. Read More

22/12/2020

NIH holds COVID-19 vaccine kick-off event

NIH Clinical Center front-line workers, Azar, Collins, Fauci to receive doses from agency’s initial stock. Read More

21/12/2020

NIH to support radical approaches to nationwide COVID-19 testing and surveillance

RADx-rad program will fund non-traditional and repurposed technologies to combat the current pandemic and address future viral disease outbreaks. Read More

19/12/2020

Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Moderna COVID-19 Vaccine

The mRNA-1273 vaccine is the second COVID-19 vaccine in the United States to be granted an EUA. Read More

17/12/2020

Investigational COVID-19 therapeutics to be evaluated in large clinical trials

NIH trial enrolling people hospitalized with COVID-19. Read More